| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 24 | / | 2020 | |||||||||
| Data sporządzenia: | 2020-11-04 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| List of Shareholders representing at least 5 % of the number of votes at the Annual General Meeting of the Shareholders on November 4, 2020 | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 70 pkt 3 Ustawy o ofercie - WZA lista powyżej 5 % | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc, “the "Company”, hereby informs that the entities named below were shareholders representing at least 5% of the number of votes at the Annual General Meeting of Shareholders held in New Jersey, USA, on November 4, 2020 “the Meeting" - Milestone Scientific Inc.- the shares held in the Company vested in Milestone Scientific the right of 21,633,084 votes at the Meeting, which accounted for 100% of the votes of the Shareholders present at the Meeting and for 98.33% of the total number of votes. | ||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
| MILESTONE MEDICAL INC | ||||||||||||||||
| (pełna nazwa emitenta) | ||||||||||||||||
| MILESTONE MEDICAL | ||||||||||||||||
| (skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | |||||||||||||||
| NJ 07039 | . | |||||||||||||||
| (kod pocztowy) | (miejscowość) | |||||||||||||||
| South Orange Avenue Livingston | 220 | |||||||||||||||
| (ulica) | (numer) | |||||||||||||||
| +11 973 535 2717 | +11 973 535 2829 | |||||||||||||||
| (telefon) | (fax) | |||||||||||||||
| (e-mail) | (www) | |||||||||||||||
| 27-5484393 | ||||||||||||||||
| (NIP) | (REGON) | |||||||||||||||
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2020-11-04 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino | ||
